Annual CAPEX
$596.26 M
+$127.16 M+27.11%
31 December 2023
Summary:
BeiGene annual capital expenditures is currently $596.26 million, with the most recent change of +$127.16 million (+27.11%) on 31 December 2023. During the last 3 years, it has risen by +$369.25 million (+162.66%). BGNE annual CAPEX is now at all-time high.BGNE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$133.66 M
+$23.70 M+21.56%
30 September 2024
Summary:
BeiGene quarterly capital expenditures is currently $133.66 million, with the most recent change of +$23.70 million (+21.56%) on 30 September 2024. Over the past year, it has dropped by -$48.64 million (-26.68%). BGNE quarterly CAPEX is now -30.77% below its all-time high of $193.05 million, reached on 31 March 2024.BGNE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$603.57 M
-$48.64 M-7.46%
30 September 2024
Summary:
BeiGene TTM capital expenditures is currently $603.57 million, with the most recent change of -$48.64 million (-7.46%) on 30 September 2024. Over the past year, it has increased by +$4.20 million (+0.70%). BGNE TTM CAPEX is now -9.06% below its all-time high of $663.73 million, reached on 31 March 2024.BGNE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGNE CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.1% | -26.7% | +0.7% |
| 3 y3 years | +162.7% | +99.4% | +185.8% |
| 5 y5 years | +323.4% | +332.9% | +191.9% |
BGNE CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +162.7% | -30.8% | +165.8% | -9.1% | +185.8% |
| 5 y | 5 years | at high | +323.4% | -30.8% | +332.9% | -9.1% | +280.5% |
| alltime | all time | at high | >+9999.0% | -30.8% | +6164.2% | -9.1% | >+9999.0% |
BeiGene CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $133.66 M(+21.6%) | $603.57 M(-7.5%) |
| June 2024 | - | $109.95 M(-43.0%) | $652.21 M(-1.7%) |
| Mar 2024 | - | $193.05 M(+15.7%) | $663.73 M(+11.3%) |
| Dec 2023 | $596.26 M(+27.1%) | $166.91 M(-8.4%) | $596.26 M(-0.5%) |
| Sept 2023 | - | $182.29 M(+50.1%) | $599.37 M(+9.8%) |
| June 2023 | - | $121.47 M(-3.3%) | $545.73 M(+15.0%) |
| Mar 2023 | - | $125.58 M(-26.1%) | $474.55 M(+1.2%) |
| Dec 2022 | $469.10 M(+49.0%) | $170.02 M(+32.2%) | $469.10 M(+2.5%) |
| Sept 2022 | - | $128.66 M(+155.8%) | $457.46 M(+15.6%) |
| June 2022 | - | $50.29 M(-58.1%) | $395.85 M(+3.1%) |
| Mar 2022 | - | $120.13 M(-24.2%) | $384.09 M(+22.0%) |
| Dec 2021 | $314.85 M(+38.7%) | $158.39 M(+136.2%) | $314.85 M(+49.1%) |
| Sept 2021 | - | $67.04 M(+74.0%) | $211.15 M(-3.7%) |
| June 2021 | - | $38.53 M(-24.3%) | $219.29 M(+2.8%) |
| Mar 2021 | - | $50.89 M(-6.9%) | $213.36 M(-6.0%) |
| Dec 2020 | $227.01 M(+43.1%) | $54.69 M(-27.3%) | $227.01 M(+9.3%) |
| Sept 2020 | - | $75.18 M(+130.6%) | $207.78 M(+27.1%) |
| June 2020 | - | $32.60 M(-49.5%) | $163.47 M(-5.1%) |
| Mar 2020 | - | $64.53 M(+82.0%) | $172.32 M(+8.6%) |
| Dec 2019 | $158.61 M | $35.46 M(+14.9%) | $158.61 M(-23.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $30.87 M(-25.5%) | $206.73 M(+1.9%) |
| June 2019 | - | $41.45 M(-18.5%) | $202.80 M(+17.9%) |
| Mar 2019 | - | $50.83 M(-39.2%) | $171.97 M(+22.1%) |
| Dec 2018 | $140.84 M(+139.8%) | $83.59 M(+210.3%) | $140.84 M(+84.9%) |
| Sept 2018 | - | $26.94 M(+153.8%) | $76.18 M(+12.0%) |
| June 2018 | - | $10.61 M(-46.1%) | $68.03 M(-4.2%) |
| Mar 2018 | - | $19.70 M(+4.0%) | $71.04 M(+21.0%) |
| Dec 2017 | $58.73 M(+149.9%) | $18.93 M(+0.8%) | $58.73 M(+22.7%) |
| Sept 2017 | - | $18.79 M(+38.0%) | $47.86 M(+33.9%) |
| June 2017 | - | $13.62 M(+84.4%) | $35.75 M(+29.6%) |
| Mar 2017 | - | $7.39 M(-8.4%) | $27.59 M(+17.4%) |
| Dec 2016 | $23.50 M(+342.3%) | $8.06 M(+20.7%) | $23.50 M(+24.6%) |
| Sept 2016 | - | $6.68 M(+22.5%) | $18.86 M(+44.6%) |
| June 2016 | - | $5.46 M(+65.2%) | $13.04 M(+142.2%) |
| Mar 2016 | - | $3.30 M(-3.5%) | $5.38 M(+1.3%) |
| Dec 2015 | $5.31 M(+712.5%) | $3.42 M(+296.1%) | $5.31 M(+180.9%) |
| Sept 2015 | - | $864.00 K(-139.2%) | $1.89 M(+84.0%) |
| June 2015 | - | -$2.20 M(-168.2%) | $1.03 M(-68.2%) |
| Mar 2015 | - | $3.23 M | $3.23 M |
| Dec 2014 | $654.00 K(+147.7%) | - | - |
| Dec 2013 | $264.00 K | - | - |
FAQ
- What is BeiGene annual capital expenditures?
- What is the all time high annual CAPEX for BeiGene?
- What is BeiGene annual CAPEX year-on-year change?
- What is BeiGene quarterly capital expenditures?
- What is the all time high quarterly CAPEX for BeiGene?
- What is BeiGene quarterly CAPEX year-on-year change?
- What is BeiGene TTM capital expenditures?
- What is the all time high TTM CAPEX for BeiGene?
- What is BeiGene TTM CAPEX year-on-year change?
What is BeiGene annual capital expenditures?
The current annual CAPEX of BGNE is $596.26 M
What is the all time high annual CAPEX for BeiGene?
BeiGene all-time high annual capital expenditures is $596.26 M
What is BeiGene annual CAPEX year-on-year change?
Over the past year, BGNE annual capital expenditures has changed by +$127.16 M (+27.11%)
What is BeiGene quarterly capital expenditures?
The current quarterly CAPEX of BGNE is $133.66 M
What is the all time high quarterly CAPEX for BeiGene?
BeiGene all-time high quarterly capital expenditures is $193.05 M
What is BeiGene quarterly CAPEX year-on-year change?
Over the past year, BGNE quarterly capital expenditures has changed by -$48.64 M (-26.68%)
What is BeiGene TTM capital expenditures?
The current TTM CAPEX of BGNE is $603.57 M
What is the all time high TTM CAPEX for BeiGene?
BeiGene all-time high TTM capital expenditures is $663.73 M
What is BeiGene TTM CAPEX year-on-year change?
Over the past year, BGNE TTM capital expenditures has changed by +$4.20 M (+0.70%)